Mycotopia Therapies Inc. To Enter $13 Billion Medicinal Mushroom Market With HAVN Life Sciences' Biopharmaceuticals And Ei.Ventures MANA Products
March 21, 2022 08:30 ET
|
Mycotopia Therapies Inc.
MIAMI, March 21, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychedelics,...
President and Co-Founder of the Schultes Center for Amazonian Ethnobotanical Research Joins Luminous Mind Inc. Scientific Advisor Network
March 10, 2022 13:00 ET
|
Luminous Mind Inc.
BOSTON, March 10, 2022 (GLOBE NEWSWIRE) -- Luminous Mind Inc. today announced the appointment of ethnobotanist, Michael J. Maki to its Scientific Advisory Network to assist in searching for...
Two esteemed doctors join CB Therapeutics in its exploration of innovative approaches to the production of novel psychedelics and cannabinoids so researchers can address the unmet needs of patient communities
December 20, 2021 08:08 ET
|
CB Therapeutics
SAN DIEGO, Dec. 20, 2021 (GLOBE NEWSWIRE) -- CB Therapeutics today announces the appointments of Dr. Stephen Wright and Dr. Brian Barnett to its newly formed Medical Advisory Board. Dr. Wright...
CB Therapeutics and atai Life Sciences launch TryptageniX to sustainably supply and develop clinically relevant compounds to tackle the growing mental health crisis
December 09, 2021 13:11 ET
|
CB Therapeutics
SAN DIEGO, Dec. 09, 2021 (GLOBE NEWSWIRE) -- CB Therapeutics, a biosynthesis company focused on creating ethical and environmentally-friendly products to improve mental health and increase...
U.S.-Based Psychedelic Healthcare VC Fund, Palo Santo, Appoints New Members to Its Advisory Board, Amid Rapid Growth in Psychedelic Sector
November 08, 2021 08:37 ET
|
Palo Santo
CHICAGO, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Palo Santo, the leading U.S.–based psychedelic investment fund, announced its advisory board, which includes some of the world’s foremost leaders in their...
Clearmind Medicine Appoints Distinguished Addiction Experts Professor Wim van den Brink and Professor Gabriele Fischer to Its Scientific Advisory Board
October 14, 2021 08:00 ET
|
Clearmind Medicine
TORONTO, Ontario, Oct. 14, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused...
Clearmind Medicine Partners With Clinipace to Commence Processes Towards FDA Approval
October 07, 2021 08:00 ET
|
Clearmind Medicine
Toronto, Ontario, Oct. 07, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0), (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused...
Tripsitter.Clinic Launches At-Home Ketamine Therapy Service Across the U.S.
September 01, 2021 11:32 ET
|
TripSitter.Clinic
AUSTIN, Texas, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Tripsitter Clinic Corp. is pleased to announce that the company is now accepting and seeing patients throughout the states of California,...
Mycotopia Therapies Signs Agreement With Havn Life Sciences For Purchase of Psilocybin SPP
August 25, 2021 08:00 ET
|
Mycotopia Therapies Inc.
MIAMI, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies, Inc. (OTC Pink: TPIA) (the “Company”), a company focused on psychedelic therapies, announced today it has entered into a Psilocybin...
InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Kelsey Ramsden, Co-Founder & CEO of Mind Cure Health Inc.
August 19, 2021 08:17 ET
|
InvestorBrandNetwork (IBN)
NEW YORK, Aug. 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...